In fact, Fiorcari et al. have recently reported that CLL patients harboring trisomy 12 have high levels of NOTCH2, leading to the upregulation of MCl-1, which in turn promotes cell survival by evading the proapoptotic effect of venetoclax [133]. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.